Characterisation of the timing of binding of the hypoxia tracer FMISO after stroke

Brain Research

Volumn 1288, Issue , 2009, Pages 135-142

  Spratt, Neil J ^a,b,c   Donnan, Geoffrey A ^a,b,c   Howells, David W ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

Disease model, Animal; Hypoxia, Brain; Infarction, Middle Cerebral Artery; Misonidazole analog and derivative diagnostic use; Radionuclide imaging; Rat, Inbred SHR

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN HYPOXIA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL VIABILITY; CORRELATION ANALYSIS; DRUG BINDING; DRUG HALF LIFE; DRUG RETENTION; HISTOLOGY; ISCHEMIC PENUMBRA; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STROKE;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CEREBROVASCULAR CIRCULATION; HYPOXIA-ISCHEMIA, BRAIN; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; MISONIDAZOLE; RADIATION-SENSITIZING AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 69049106306     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.06.102     Document Type: Article

References (18)

1. Aspey B.S., Cohen S., Patel Y., Terruli M., and Harrison M.J. Middle cerebral artery occlusion in the rat: consistent protocol for a model of stroke. Neuropathol. Appl. Neurobiol. 24 (1998) 487-497
2. Baron J.C. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc. Dis. 9 (1999) 193-201
3. Donnan G.A., Baron J.-C., Davis S.M., and Sharp F.R. The ischaemic penumbra, overview, definition and criteria. In: Donnan G., Baron J.C., and Davis S. (Eds). The Ischaemic Penumbra: Pathophysiology, Imaging and Therapy (2007), Informa Healthcare, New York, London 149-164
4. Heiss W.-D. Ischemic penumbra: evidence from functional imaging in man. J. Cereb. Blood Flow Metab. 20 (2000) 1276-1293
5. Koh W.J., Rasey J.S., Evans M.L., Grierson J.R., Lewellen T.K., Graham M.M., Krohn K.A., and Griffin T.W. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phys. 22 (1992) 199-212
6. Koizumi J., Yoshida Y., Nakazawa T., and Ooneda G. Experimental studies of ischemic brain edema: 1. A new experimental model of experimental embolism in rats in which recirculation can be reintroduced in the ischemic area. Jpn. J. Stroke 8 (1986) 1-8
7. Liberatore G.T., Wong J.Y., Krenus D., Jeffreys B.J., Porritt M.J., and Howells D.W. Tissue fixation prevents contamination of tritium-sensitive storage phosphor imaging plates. Biotechniques 26 (1999) 432-434
8. Liu R.S., Chu L.S., Yen S.H., Chang C.P., Chou K.L., Wu L.C., Chang C.W., Lui M.T., Chen K.Y., and Yeh S.H. Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole. Eur. J. Nucl. Med. 23 (1996) 1384-1387
9. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
10. Markus R., Reutens D.C., Kazui S., Read S., Wright P., Pearce D.C., Tochon-Danguy H.J., Sachinidis J.I., and Donnan G.A. Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. Brain 127 (2004) 1427-1436
11. Martin G.V., Caldwell J.H., Graham M.M., Grierson J.R., Kroll K., Cowan M.J., Lewellen T.K., Rasey J.S., Casciari J.J., and Krohn K.A. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography. J. Nucl. Med. 33 (1992) 2202-2208
12. Nunn A., Linder K., and Strauss H.W. Nitroimidazoles and imaging hypoxia. Eur. J. Nucl. Med. 22 (1995) 265-280
13. Read S.J., Hirano T., Abbott D.F., Sachinidis J.I., Tochon-Danguy H.J., Chan J.G., Egan G.F., Scott A.M., Bladin C.F., McKay W.J., and Donnan G.A. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology 51 (1998) 1617-1621
14. Saita K., Chen M., Spratt N.J., Porritt M.J., Liberatore G.T., Read S.J., Levi C.R., Donnan G.A., Ackermann U., Tochon-Danguy H.J., Sachinidis J.I., and Howells D.W. Imaging the ischemic penumbra with 18F-fluoromisonidazole in a rat model of ischemic stroke. Stroke 35 (2004) 975-980
15. Spratt N.J., Ackerman U., Tochon-Danguy H.J., Donnan G.A., and Howells D.W. Characterization of fluoromisonidazole binding in stroke. Stroke 37 (2006) 1862-1867
16. Spratt N.J., Fernandez J., Chen M., Rewell S., Cox S., van Raay L., Hogan L., and Howells D.W. Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats. J. Neurosci. Methods 155 (2006) 285-290
17. Takasawa M., Beech J.S., Fryer T.D., Hong Y.T., Hughes J.L., Igase K., Jones P.S., Smith R., Aigbirhio F.I., Menon D.K., Clark J.C., and Baron J.C. Imaging of brain hypoxia in permanent and temporary middle cerebral artery occlusion in the rat using 18F-fluoromisonidazole and positron emission tomography: a pilot study. J. Cereb. Blood Flow Metab. 27 (2007) 679-689
18. Takasawa M., Moustafa R.R., and Baron J.-C. Applications of nitroimidazole in vivo hypoxia imaging in ischemic stroke. Stroke 39 (2008) 1629-1637 (May)